We are international

The IMF’s advocacy action initiatives are based on five simple principles that are relevant not just to myeloma patients but to cancer patients in general.

Statement of Principles

Prevention - the key to reducing the burden of cancer.

Innovation - critical to early diagnosis and more effective and safer treatment

Equality of access - should be available for all patients to all approved treatments.

Early Approval - National policies and procedures for early approval of new treatments need to be reformed and streamlined.

Experimental Therapies - A mechanism is needed to permit access to unapproved and experimental therapies for patients who have exhausted other available possibilities.